Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
N. Anthony Coles currently holds 10,290 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, N. Anthony Coles has been a net seller of CRSP stock. They have purchased $0 and sold $79.1M worth of shares.
N. Anthony Coles's most recent insider trade was on Aug 1, 2024, when they sold 46,322 shares at $0.00 per share.
N. Anthony Coles serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 185 insider transactions totaling $79.1M over their tenure at the company.
N. Anthony Coles holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
N. Anthony Coles has shown a selling trading pattern, with $0 in total purchases and $79.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by N. Anthony Coles was on Apr 1, 2024, when they sold $2.1M worth of CERE shares. This transaction involved 50,000 shares at $42.33 per share.
N. Anthony Coles currently owns 10,290 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of N. Anthony Coles's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. N. Anthony Coles has 185 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for N. Anthony Coles and 40,000+ other insiders.